By contrast, CD146+ CAFs maintain the expression of ER in ER+ breast cancer cells and sustain sensitivity to Tamoxifen (Brechbuhl et al., 2017), suggesting that similar subsets of CAFs can have distinct functions within different cancer subtypes. Here, MCAM is linked to breast cancer.